LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will be presenting at the 2012 Biotechnology Industry Organization CEO & Investor Conference on Monday, February 13 at 9:30 am (ET) in New York.
